Journal articleEur Rev Med Pharmacol Sci2020
Metformin reduces pancreatic cancer cell proliferation and increases apoptosis through MTOR signaling pathway and its dose-effect relationship.
- Journal
- Eur Rev Med Pharmacol Sci
- Published
- 1 May 2020
- Citations
- 13
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Objective To study the influences of metformin on the proliferation and apoptosis of pancreatic cancer cells and its dose-effect relationship and crucial molecular mechanism. Materials and methods With human pancreatic cancer cell line PANC-1 as the study object, different concentrations of metformin were added for intervention. … Excerpt only: this text is the publisher’s. Read it in full at the source.